HELICOS BIOSCIENCES CORP 8-K 2008
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 28, 2008
HELICOS BIOSCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
(Registrants telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
(d) The Board of Directors of Helicos BioSciences Corporation (Helicos or the Company) elected Elisabeth K. Allison, PhD to serve as a member of the Companys Board of Directors effective January 28, 2008. Dr. Allison will serve as a Class I Director whose initial term will expire at the annual meeting of stockholders held in 2008. Dr. Allison is currently a principal at ANZI Partners, a transactional firm specializing in acquisitions, strategic partnerships, joint ventures, licensing, and distribution agreements in the publishing and software industries since 1995. The Board has not yet determined what committees Dr. Allison may serve on. There are no arrangements between Dr. Allison and any other persons pursuant to Dr. Allison was selected as a director. There are no transactions, or proposed transactions, to which the Company is or was to be party and in which Dr. Allison had a direct or indirect material interest that are required to be disclosed under Item 404(a) of Regulation S-K. A copy of the press release announcing Dr. Allisons election is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 31, 2008
INDEX OF EXHIBITS